blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1416791

EP1416791 - AN ANIMAL MODEL EXHIBITING CANCER, PULMONARY EMPHYSEMA AND CARDIOMYOPATHY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.03.2007
Database last updated on 23.04.2024
Most recent event   Tooltip22.05.2015Change - lapse in a contracting state
State(s) deleted from list of lapses: LI		published on 24.06.2015  [2015/26]
Applicant(s)For all designated states
FrankGen Biotechnologie AG
Wilhelm-Bonn-Strasse 8f
61476 Kronberg/Taunus / DE
[2004/20]
Inventor(s)01 / MELCHNER, Harald von
Wilhelm-Bonn-Strasse 8F
61476 Kronbert/Taunus / DE
02 / THOREY, Irmgard
Noderstrasse 3
81245 München / DE
03 / WEMPE, Frank
Müllerweg 67
63165 Mühlheim am Main / DE
04 / STERNER-KOCK, Anja, Institut für Veterinärspatholo
Robert-von-Ostertag-Str. 15
14163 Berlin / DE
05 / KESKI-OJA, Jorma
Osuuskunnantie 45
FIN-00660 Helsinki / FI
 [2004/37]
Former [2004/20]01 / MELCHNER, Harald von
Wilhelm-Bonn-Strasse 8F
61476 Kronbert/Taunus / DE
02 / THOREY, Irmgard, S.
Winterthurer Strasse 344
CH-8057 Zürich / CH
03 / WEMPE, Frank
Müllerweg 67
63165 Mühlheim am Main / DE
04 / STERNER-KOCK, Anja
An den Tannen 21
64546 Mörfelden-Walldorf / DE
05 / KESKI-OJA, Jorma
Osuuskunnantie 45
FIN-00660 Helsinki / FI
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[N/P]
Former [2009/47]Helbing, Jörg, et al
Patentanwälte von Kreisler Selting Werner Postfach 10 22 41
50462 Köln / DE
Former [2005/42]Helbing, Jörg, et al
Patentanwälte von Kreisler Selting Werner Postfach 10 22 41
50462 Köln / DE
Former [2004/20]Grund, Martin, Dr., et al
Dr. Volker Vossius Patent- & Rechtsanwaltskanzlei Geibelstrasse 6
81679 München / DE
Application number, filing date02767366.412.08.2002
[2004/20]
WO2002EP09011
Priority number, dateUS20010312164P14.08.2001         Original published format: US 312164 P
[2004/20]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03015505
Date:27.02.2003
Language:EN
[2003/09]
Type: A2 Application without search report 
No.:EP1416791
Date:12.05.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 27.02.2003 takes the place of the publication of the European patent application.
[2004/20]
Type: B1 Patent specification 
No.:EP1416791
Date:24.05.2006
Language:EN
[2006/21]
Search report(s)International search report - published on:EP02.10.2003
ClassificationIPC:A01K67/027, C07K14/475, C07K14/495
[2005/50]
CPC:
A01K67/0275 (EP,US); C07K14/78 (EP,US); C12N15/8509 (EP,US);
A01K2217/05 (EP,US); A01K2217/075 (EP,US); A01K2227/105 (EP,US);
A01K2267/03 (EP,US); A01K2267/0331 (EP,US); A01K2267/0375 (EP,US);
C12N2800/30 (EP,US); C12N2830/008 (EP,US) (-)
Former IPC [2004/20]A01K67/027
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/20]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:TIERMODELL MIT KREBS, LUNGENEMPHYSEM UND KARDIOMYOPATHIE[2004/20]
English:AN ANIMAL MODEL EXHIBITING CANCER, PULMONARY EMPHYSEMA AND CARDIOMYOPATHY[2004/20]
French:MODELE ANIMAL PRESENTANT UN CANCER, UN EMPHYSEME PULMONAIRE ET UNE CARDIOMYOPATHIE[2004/20]
Entry into regional phase09.01.2004National basic fee paid 
09.01.2004Designation fee(s) paid 
09.01.2004Examination fee paid 
Examination procedure09.01.2004Examination requested  [2004/20]
14.04.2004Despatch of a communication from the examining division (Time limit: M04)
20.07.2004Reply to a communication from the examining division
04.08.2004Despatch of a communication from the examining division (Time limit: M04)
13.12.2004Reply to a communication from the examining division
04.02.2005Despatch of a communication from the examining division (Time limit: M04)
06.05.2005Reply to a communication from the examining division
20.05.2005Despatch of a communication from the examining division (Time limit: M04)
21.09.2005Reply to a communication from the examining division
10.11.2005Communication of intention to grant the patent
10.03.2006Fee for grant paid
10.03.2006Fee for publishing/printing paid
Opposition(s)27.02.2007No opposition filed within time limit [2007/18]
Fees paidRenewal fee
27.08.2004Renewal fee patent year 03
31.08.2005Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT24.05.2006
BE24.05.2006
CY24.05.2006
CZ24.05.2006
EE24.05.2006
FI24.05.2006
NL24.05.2006
SK24.05.2006
TR24.05.2006
LU12.08.2006
IE14.08.2006
BG24.08.2006
DK24.08.2006
GR25.08.2006
MC31.08.2006
ES04.09.2006
PT24.10.2006
[2015/26]
Former [2009/03]AT24.05.2006
BE24.05.2006
CY24.05.2006
CZ24.05.2006
EE24.05.2006
FI24.05.2006
LI24.05.2006
NL24.05.2006
SK24.05.2006
TR24.05.2006
LU12.08.2006
IE14.08.2006
BG24.08.2006
DK24.08.2006
GR25.08.2006
MC31.08.2006
ES04.09.2006
PT24.10.2006
Former [2008/37]AT24.05.2006
BE24.05.2006
CZ24.05.2006
EE24.05.2006
FI24.05.2006
LI24.05.2006
NL24.05.2006
SK24.05.2006
TR24.05.2006
LU12.08.2006
IE14.08.2006
BG24.08.2006
DK24.08.2006
GR25.08.2006
MC31.08.2006
ES04.09.2006
PT24.10.2006
Former [2008/31]AT24.05.2006
BE24.05.2006
CZ24.05.2006
EE24.05.2006
FI24.05.2006
LI24.05.2006
NL24.05.2006
SK24.05.2006
IE14.08.2006
BG24.08.2006
DK24.08.2006
GR25.08.2006
MC31.08.2006
ES04.09.2006
PT24.10.2006
Former [2008/28]AT24.05.2006
BE24.05.2006
CZ24.05.2006
EE24.05.2006
FI24.05.2006
LI24.05.2006
NL24.05.2006
SK24.05.2006
IE14.08.2006
DK24.08.2006
GR25.08.2006
MC31.08.2006
ES04.09.2006
PT24.10.2006
Former [2008/21]AT24.05.2006
BE24.05.2006
CZ24.05.2006
FI24.05.2006
LI24.05.2006
NL24.05.2006
SK24.05.2006
IE14.08.2006
DK24.08.2006
GR25.08.2006
MC31.08.2006
ES04.09.2006
PT24.10.2006
Former [2007/45]AT24.05.2006
BE24.05.2006
CZ24.05.2006
FI24.05.2006
LI24.05.2006
NL24.05.2006
SK24.05.2006
IE14.08.2006
DK24.08.2006
MC31.08.2006
ES04.09.2006
PT24.10.2006
Former [2007/42]AT24.05.2006
BE24.05.2006
CZ24.05.2006
FI24.05.2006
IT24.05.2006
LI24.05.2006
NL24.05.2006
SK24.05.2006
IE14.08.2006
DK24.08.2006
MC31.08.2006
ES04.09.2006
PT24.10.2006
Former [2007/39]AT24.05.2006
BE24.05.2006
CZ24.05.2006
FI24.05.2006
IT24.05.2006
LI24.05.2006
NL24.05.2006
SK24.05.2006
DK24.08.2006
MC31.08.2006
ES04.09.2006
PT24.10.2006
Former [2007/19]AT24.05.2006
BE24.05.2006
CZ24.05.2006
FI24.05.2006
LI24.05.2006
NL24.05.2006
SK24.05.2006
DK24.08.2006
MC31.08.2006
ES04.09.2006
PT24.10.2006
Former [2007/13]AT24.05.2006
BE24.05.2006
CZ24.05.2006
FI24.05.2006
LI24.05.2006
SK24.05.2006
DK24.08.2006
ES04.09.2006
PT24.10.2006
Former [2007/12]AT24.05.2006
CH24.05.2006
CZ24.05.2006
FI24.05.2006
LI24.05.2006
SK24.05.2006
DK24.08.2006
ES04.09.2006
PT24.10.2006
Former [2007/11]AT24.05.2006
CH24.05.2006
CZ24.05.2006
FI24.05.2006
LI24.05.2006
SK24.05.2006
DK24.08.2006
ES04.09.2006
Former [2007/03]AT24.05.2006
CH24.05.2006
FI24.05.2006
LI24.05.2006
ES04.09.2006
Former [2006/52]AT24.05.2006
FI24.05.2006
ES04.09.2006
Former [2006/50]ES04.09.2006
Cited inInternational search[A]EP1092768  (ARTEMIS PHARMACEUTICALS GMBH [DE], et al) [A] 1-24* the whole document *;
 [PX]  - VON MELCHNER HARALD ET AL, "Disruption of the gene encoding the latent transforming growth factor beta binding protein 4 (LTBP4) causes severe pulmonary emphysema, cardiomyopathy and colorectal cancer.", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL, 93rd Annual Meeting of the American Association for Cancer Research;San Francisco, California, USA; April 06-10, 2002, March, 2002, (200203), vol. 43, ISSN 0197-016X, page 342, XP001153301 [PX] 1-24 * abstract *
 [Y]  - SAHARINEN JUHA ET AL, "Identification and characterization of a new latent transforming growth factor-beta-binding protein, LTBP-4.", JOURNAL OF BIOLOGICAL CHEMISTRY, (19980717), vol. 273, no. 29, ISSN 0021-9258, pages 18459 - 18469, XP002246446 [Y] 1-24 * figures 1,3 *

DOI:   http://dx.doi.org/10.1074/jbc.273.29.18459
 [Y]  - SHIPLEY J MICHAEL ET AL, "Developmental expression of latent transforming growth factor beta binding protein 2 and its requirement early in mouse development.", MOLECULAR AND CELLULAR BIOLOGY, (200007), vol. 20, no. 13, ISSN 0270-7306, pages 4879 - 4887, XP002246447 [Y] 1-24 * page 4880 *

DOI:   http://dx.doi.org/10.1128/MCB.20.13.4879-4887.2000
 [A]  - OEKLUE R ET AL, "THE LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP) FAMILY", BIOCHEMICAL JOURNAL, THE BIOCHEMICAL SOCIETY, LONDON, GB, (20001015), vol. 352, no. 3, ISSN 0264-6021, pages 601 - 610, XP009010129 [A] * the whole document *

DOI:   http://dx.doi.org/10.1042/0264-6021:3520601
 [T]  - STERNER-KOCK ANJA ET AL, "Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer.", GENES & DEVELOPMENT, September 1, 2002, (20020901), vol. 16, no. 17, ISSN 0890-9369, pages 2264 - 2273, XP002246448 [T] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1101/gad.229102
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.